IQVIA Holdings Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über IQVIA Holdings Inc Unternehmen

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc Informationen



BörsenkürzelIQV

Name des UnternehmensIQVIA Holdings Inc

IPO-datumMay 09, 2013

CEOBousbib (Ari)

Anzahl der mitarbeiter88000

WertpapierartOrdinary Share

GeschäftsjahresendeMay 09

Addresse2400 Ellis Road

StadtDURHAM

BörseNASDAQ OMX NASDAQ Basic NYSE

LandUnited States of America

Postleitzahl27703

Telefon19199982000

Websitehttps://ir.iqvia.com/

BörsenkürzelIQV

IPO-datumMay 09, 2013

CEOBousbib (Ari)

Führungskräfte von IQVIA Holdings Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

Ms. Carol J. Burt

Independent Director

7.01K

+1047.00%

Mr. James A. Fasano

Independent Director

2.74K

+1676.00%

Mr. John P. Connaughton

Independent Director

1.05K

+1047.00%

Mr. Bhavik Patel

President, Commercial Solutions

863.00

-84.00%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Nach RegionUSD

Name

Umsatz

Anteil

Americas

1.93B

47.15%

Europe & Africa Region

1.30B

31.63%

Asia Pacific Region

870.00M

21.22%

Nach Geschäftsbereich

Nach Region

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sat, Jan 10

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

Andere

67.87%

Aktionäre

Anteil

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

Andere

67.87%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

47.72%

Investment Advisor/Hedge Fund

36.41%

Sovereign Wealth Fund

4.96%

Pension Fund

4.15%

Hedge Fund

3.24%

Research Firm

2.37%

Bank and Trust

2.01%

Individual Investor

0.92%

Family Office

0.15%

Institutionelle Beteiligung



Aktualisiert: Thu, Jan 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

2121

171.05M

100.44%

-15.70M

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

2023Q3

1925

170.01M

92.82%

-4.41M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

19.41M

11.4%

-186.59K

-0.95%

Sep 30, 2025

Harris Associates L.P.

11.39M

6.69%

-365.92K

-3.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

9.44M

5.54%

+67.42K

+0.72%

Sep 30, 2025

State Street Investment Management (US)

7.55M

4.43%

-75.92K

-1.00%

Sep 30, 2025

GIC Private Limited

6.54M

3.84%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.35M

2.55%

+132.36K

+3.14%

Sep 30, 2025

CPP Investments

4.12M

2.42%

-52.91K

-1.27%

Sep 30, 2025

AllianceBernstein L.P.

3.60M

2.11%

+41.64K

+1.17%

Sep 30, 2025

Boston Partners

3.56M

2.09%

+1.58M

+80.09%

Sep 30, 2025

Artisan Partners Limited Partnership

3.43M

2.02%

+161.09K

+4.92%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Tue, Dec 2

Name

Anteil

First Trust Nasdaq Lux Digi Health Solutions ETF

9.1%

Langar Global HealthTech ETF

7.83%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.98%

iShares Biotechnology ETF

3.23%

iShares Health Innovation Active ETF

3.05%

Adaptive Core ETF

3.04%

Invesco Bloomberg Pricing Power ETF

2.24%

Running Oak Efficient Growth ETF

2.16%

Invesco Zacks Mid-Cap ETF

2.08%

First Trust Nasdaq Lux Digi Health Solutions ETF

Anteil9.1%

Langar Global HealthTech ETF

Anteil7.83%

Global X HealthTech ETF

Anteil5.5%

VanEck Biotech ETF

Anteil4.98%

iShares Biotechnology ETF

Anteil3.23%

iShares Health Innovation Active ETF

Anteil3.05%

Adaptive Core ETF

Anteil3.04%

Invesco Bloomberg Pricing Power ETF

Anteil2.24%

Running Oak Efficient Growth ETF

Anteil2.16%

Invesco Zacks Mid-Cap ETF

Anteil2.08%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten